C. Dewas-Vautravers

Papers

Total Citations

H-Index

About

C. Dewas-Vautravers is a leading radiation oncologist whose research focuses on stereotactic body radiation therapy (SBRT) for hepatic tumors, with a particular emphasis on optimizing local control and minimizing toxicity. Their most-cited work, a 2012 study with 68 citations, systematically analyzed prognostic factors affecting local control in primary and secondary liver tumors treated with robotic SBRT and real-time tumor tracking. This seminal paper provided critical insights into dose-response relationships and tumor characteristics that predict treatment success, helping to refine patient selection and treatment planning protocols. By demonstrating that SBRT achieves encouraging efficacy with low toxicity for hepatic lesions, Dewas-Vautravers contributed to establishing SBRT as a viable, non-invasive alternative for patients who are not surgical candidates. Their work has influenced clinical practice in radiation oncology, particularly in the management of liver metastases and primary hepatocellular carcinoma. Through rigorous analysis of treatment outcomes, Dewas-Vautravers has advanced the understanding of how to maximize the therapeutic ratio in liver SBRT, making a lasting impact on the field of stereotactic radiotherapy.